Valerio Therapeutics Société anonyme (FRA:C4X)
0.161
-0.005 (-3.01%)
At close: Dec 4, 2025
FRA:C4X Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -13.18 | -23.93 | -20.34 | -19.56 | -5.94 | 1.09 | Upgrade
|
| Depreciation & Amortization | 11.58 | 12.98 | 0.48 | 0.53 | 0.6 | 0.53 | Upgrade
|
| Other Amortization | - | - | - | - | - | 0.06 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.86 | -0.79 | - | - | - | 0.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.21 | -0.18 | -0.29 | Upgrade
|
| Stock-Based Compensation | 0.27 | 0.39 | 0.51 | 0.72 | 0.22 | 0.08 | Upgrade
|
| Other Operating Activities | 3.07 | 2.98 | 2.63 | 1.78 | 0.86 | -7.09 | Upgrade
|
| Change in Other Net Operating Assets | -10.1 | -4.09 | -0.67 | 6.88 | -4.14 | 0.89 | Upgrade
|
| Operating Cash Flow | -9.23 | -12.46 | -17.39 | -9.44 | -8.57 | -4.68 | Upgrade
|
| Capital Expenditures | -0.39 | -0.32 | -0.18 | -0.49 | -0.14 | -0.12 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.14 | - | - | - | - | 6.12 | Upgrade
|
| Divestitures | -1.08 | -1.08 | - | - | - | 0.01 | Upgrade
|
| Investment in Securities | 0.01 | 0.01 | 0.01 | 0.08 | 0.07 | 0 | Upgrade
|
| Other Investing Activities | 0 | 0 | -0 | -0 | - | - | Upgrade
|
| Investing Cash Flow | -1.32 | -1.39 | -0.18 | -0.41 | -0.07 | 6.02 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 3.11 | - | Upgrade
|
| Total Debt Issued | 0.39 | - | - | - | 3.11 | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.36 | -1.23 | -1.51 | -0.49 | -3.09 | Upgrade
|
| Net Debt Issued (Repaid) | -0.56 | -1.36 | -1.23 | -1.51 | 2.62 | -3.09 | Upgrade
|
| Issuance of Common Stock | 0.07 | 0.02 | 12.14 | 7.97 | 9.35 | 10.58 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.13 | - | - | - | Upgrade
|
| Other Financing Activities | 5.54 | 5.54 | -0.03 | 0 | 0 | -0 | Upgrade
|
| Financing Cash Flow | 5.05 | 4.21 | 10.76 | 6.46 | 11.98 | 7.48 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.04 | -0.12 | 0.24 | 0.09 | 0.03 | -0 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 4.09 | 4.09 | -1.21 | 0 | - | - | Upgrade
|
| Net Cash Flow | -1.37 | -5.66 | -7.77 | -3.3 | 3.36 | 8.82 | Upgrade
|
| Free Cash Flow | -9.62 | -12.78 | -17.57 | -9.93 | -8.71 | -4.8 | Upgrade
|
| Free Cash Flow Margin | -525.41% | -712.72% | -976.33% | -688.22% | -214.45% | -270.10% | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.08 | -0.13 | -0.09 | -0.10 | -0.06 | Upgrade
|
| Levered Free Cash Flow | 5.47 | 5.57 | -9.83 | -2.92 | -7.36 | -8.97 | Upgrade
|
| Unlevered Free Cash Flow | 5.73 | 5.77 | -9.7 | -1.55 | -6.83 | -8.37 | Upgrade
|
| Change in Working Capital | -10.1 | -4.09 | -0.67 | 6.88 | -4.14 | 0.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.